ES2057071T3 - Peptidos con efecto antagonista de bradiquinina. - Google Patents

Peptidos con efecto antagonista de bradiquinina.

Info

Publication number
ES2057071T3
ES2057071T3 ES89121498T ES89121498T ES2057071T3 ES 2057071 T3 ES2057071 T3 ES 2057071T3 ES 89121498 T ES89121498 T ES 89121498T ES 89121498 T ES89121498 T ES 89121498T ES 2057071 T3 ES2057071 T3 ES 2057071T3
Authority
ES
Spain
Prior art keywords
amino acid
bradiquinine
peptide
peptides
rest
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89121498T
Other languages
English (en)
Inventor
Stephan Dr Henke
Hiristo Anagnostopulos
Gerhard Dr Breipohl
Jochen Dr Knolle
Jens Dr Stechel
Bernward Prof Dr Scholkens
Hans-Wolfram Dr Fehlhaber
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Application granted granted Critical
Publication of ES2057071T3 publication Critical patent/ES2057071T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/18—Kallidins; Bradykinins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Abstract

EL INVENTO SE REFIERE A UN PEPTIDO DE FORMULA (I), QUE TIENE UNA ACCION ANTAGONISTA DE BRADIQUININA, SE UTILIZA COMO TERAPEUTICO FRENTE A TODOS LOS ESTADOS PATOLOGICOS; SE PRODUCE SEGUN METODOS CONOCIDOS DE LA SINTESIS DE PEPTIDOS Y SE DESDOBLA O SE SOSTIENE A TRAVES DE LA BRADIQUININA Y TRATA DE LA BRADIQUININA EMPLEADA PARA INTERVENIR AL PEPTIDO. SIENDO: A HIDROGENO, ALQUILO, ALCANOILO, ALCOXICARBONILO, ALQUISULFONILO, CICLOALQUILO, ARILO, ARILSULFONILO, HETEROARILO O UN AMINOACIDO; B UN AMINOACIDO BASICO; C UN DI O TRIPEPTIDO; E EL RESTO DE UN AMINOACIDO AROMATICO; F UN AMINOACIDO SUSTITUIDO EN LA CADENA LATERAL O UN ENLACE DIRECTO; G UN AMINOACIDO; F'', F, -NH-(CH2)DE C 2 A 8, -CO- O UN ENLACE DIRECTO; I -OH, NH2 O _NHC2H5; Y K EL RESTO -NH-(CH2) DE C 1 A 4, -CO-.
ES89121498T 1988-11-24 1989-11-21 Peptidos con efecto antagonista de bradiquinina. Expired - Lifetime ES2057071T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE3839581 1988-11-24
DE3916291 1989-05-19
DE3918225 1989-06-03

Publications (1)

Publication Number Publication Date
ES2057071T3 true ES2057071T3 (es) 1994-10-16

Family

ID=27198531

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89121498T Expired - Lifetime ES2057071T3 (es) 1988-11-24 1989-11-21 Peptidos con efecto antagonista de bradiquinina.

Country Status (26)

Country Link
EP (1) EP0370453B1 (es)
JP (1) JPH07121956B2 (es)
KR (1) KR0139632B1 (es)
CN (1) CN1035006C (es)
AT (1) ATE107318T1 (es)
AU (1) AU612054B2 (es)
CA (1) CA1340667C (es)
CY (2) CY2028A (es)
CZ (1) CZ282384B6 (es)
DE (3) DE58907889D1 (es)
DK (1) DK175344B1 (es)
ES (1) ES2057071T3 (es)
FI (1) FI94353C (es)
HK (1) HK1006716A1 (es)
HU (2) HU210566B (es)
IE (1) IE63490B1 (es)
IL (1) IL91298A (es)
LU (1) LU91499I2 (es)
LV (1) LV10720B (es)
MX (1) MX9203277A (es)
NL (1) NL300359I2 (es)
NO (2) NO177597C (es)
NZ (1) NZ230244A (es)
PH (1) PH31009A (es)
PT (1) PT91692B (es)
SK (1) SK490689A3 (es)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5648333A (en) * 1988-11-24 1997-07-15 Hoechst Aktiengesellschaft Peptides having bradykinin antagonist action
DE4013270A1 (de) * 1990-04-26 1991-10-31 Hoechst Ag Peptide mit bradykinin-antagonistischer wirkung
EP0502987B1 (en) * 1989-12-08 1994-08-31 Trustees Of Boston University Acylated bradykinin antagonists and uses therefor
MX9100717A (es) * 1990-08-24 1992-04-01 Syntex Inc Antagonistas de la bradiquinina
US5843900A (en) * 1991-04-01 1998-12-01 Cortech, Inc. Bradykinin antagonists
US5416191A (en) * 1991-04-01 1995-05-16 Cortech, Inc. Bradykinin antagonists
ATE202708T1 (de) * 1991-04-19 2001-07-15 Scios Nova Inc Peptidantagonisten des bradykinin
JP3465000B2 (ja) * 1991-04-19 2003-11-10 シオス・ノヴァ・インコーポレイティット ブラジキニン型ペプチド
US6770741B1 (en) 1991-04-19 2004-08-03 Scios Inc. Bradykinin antagonist peptides
HUT63060A (en) * 1991-08-22 1993-07-28 Hoechst Ag Process for producing pharmaceutical compositions locally applicable on nose and eye, comprising bradykinin antagonists
US6117974A (en) * 1991-10-02 2000-09-12 Peptor Limited Libraries of backbone-cyclized peptidomimetics
WO1993011789A1 (en) 1991-12-12 1993-06-24 Scios Nova Inc. Modified position (7) bradykinin antagonist peptides
TW199863B (es) * 1991-12-21 1993-02-11 Hoechst Ag
WO1993017701A1 (en) * 1992-03-12 1993-09-16 The Administrators Of The Tulane Educational Fund Endothelin receptor-binding peptides
TW258739B (es) * 1992-04-04 1995-10-01 Hoechst Ag
FR2692581B1 (fr) * 1992-06-18 1994-08-19 Adir Nouveaux dérivés peptidiques à activité antagoniste de la bradykinine, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
US5541286A (en) * 1992-10-08 1996-07-30 Scios Nova Inc. Bradykinin antagonist pseudopeptide derivatives of olefinic aminoalkanoic acids
US5521158A (en) * 1992-10-08 1996-05-28 Scios Nova Inc. Pseudopeptide bradykinin receptor antagonists
US5610142A (en) * 1992-10-08 1997-03-11 Scios Inc. Bradykinin antagonist pseudopeptide derivatives of substituted 4-keto-1,3,8-triazaspiro[4.5]decan-3-alkanoic acids
US5686565A (en) * 1992-10-08 1997-11-11 Scios Inc. Bradykinin antagonist pseudopeptide derivatives of aminoalkanoic acids and related olefins
IL107400A0 (en) * 1992-11-10 1994-01-25 Cortech Inc Bradykinin antagonists
WO1994019372A1 (en) * 1993-02-17 1994-09-01 Scios Nova Inc. Cyclic bradykinin antagonist peptides
US5817756A (en) * 1993-09-09 1998-10-06 Scios Inc. Pseudo- and non-peptide bradykinin receptor antagonists
DE4345062A1 (de) * 1993-12-31 1995-07-13 Hoechst Ag Verwendung von Bradykinin-Antagonisten zur Herstellung von Arzneimitteln zur Behandlung von Viruserkrankungen
AU696429B2 (en) * 1994-03-09 1998-09-10 Cortech, Inc. Bradykinin antagonist peptides incorporating n-substituted glycines
US6407059B1 (en) 1994-06-08 2002-06-18 Peptor Limited Conformationally constrained backbone cyclized peptide analogs
IL109943A (en) * 1994-06-08 2006-08-01 Develogen Israel Ltd Conformationally constrained backbone cyclized peptide analogs
EP0832106A2 (en) * 1995-06-05 1998-04-01 Cortech, Inc. Compounds having bradykinin antagonistic activity and mu-opioid agonistic activity
US6051554A (en) * 1995-06-07 2000-04-18 Peptor Limited Conformationally constrained backbone cyclized somatostatin analogs
US5770687A (en) * 1995-06-07 1998-06-23 Peptor Limited Comformationally constrained backbone cyclized somatostatin analogs
FR2737408B1 (fr) * 1995-07-31 1997-09-05 Oreal Utilisation d'un antagoniste de bradykinine dans une composition cosmetique, pharmaceutique ou dermatologique et composition obtenue
US5849863A (en) * 1995-09-08 1998-12-15 University Of Colorado Cytolytic bradykinin antagonists
US5834431A (en) * 1995-09-08 1998-11-10 Cortech, Inc. Des-Arg9 -BK antagonists
FR2739553B1 (fr) * 1995-10-06 1998-01-02 Oreal Utilisation d'antagonistes de la bradykinine pour stimuler ou induire la pousse des cheveux et/ou stopper leur chute
US6841533B1 (en) 1995-12-07 2005-01-11 Peptor Limited Conformationally constrained backbone cyclized interleukin-6 antagonists
DE19612067A1 (de) * 1996-03-27 1997-10-02 Hoechst Ag Verwendung von Bradykinin-Antagonisten zur Herstellung von Arzneimitteln zur Behandlung von chronisch fibrogenetischen Lebererkrankungen und akuten Lebererkrankungen
US6355613B1 (en) 1996-07-31 2002-03-12 Peptor Limited Conformationally constrained backbone cyclized somatostatin analogs
DE19642289A1 (de) * 1996-10-14 1998-04-16 Hoechst Ag Verwendung von Bradykinin-Antagonisten zur Herstellung von Arzneimitteln zur Behandlung und Prävention der Alzheimer'schen Krankheit
DE10304994A1 (de) * 2003-02-07 2004-09-02 Aventis Pharma Deutschland Gmbh Die Verwendung von Antagonisten des Bradykinin-B2 Rezeptors zur Behandlung von Osteoarthrose
CN102532267B (zh) * 2012-02-09 2014-06-18 深圳翰宇药业股份有限公司 一种艾替班特的制备方法
CN104043101B (zh) * 2014-05-23 2016-04-20 杭州阿德莱诺泰制药技术有限公司 一种艾替班特注射用组合物及其制备方法和制剂
KR102099509B1 (ko) 2018-07-27 2020-04-09 강경순 과수용 받침지주
CN111944016B (zh) * 2020-08-25 2022-04-29 台州吉诺生物科技有限公司 一种醋酸艾替班特的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3044236A1 (de) * 1980-11-25 1982-06-16 Hoechst Ag, 6000 Frankfurt Aminosaeurederivate und verfahren zu ihrer herstellung
FR2487829A2 (fr) * 1979-12-07 1982-02-05 Science Union & Cie Nouveaux imino acides substitues, leurs procedes de preparation et leur emploi comme inhibiteur d'enzyme
DE3227055A1 (de) * 1982-07-20 1984-01-26 Hoechst Ag, 6230 Frankfurt Neue derivate der 2-aza-bicyclo(2.2.2)octan-3-carbonsaeure, verfahren zu ihrer herstellung, diese enthaltende mittel und deren verwendung sowie 2-aza-bicyclo(2.2.2)octan-3-carbonsaeure als zwischenstufe und verfahren zu deren herstellung
FR2575753B1 (fr) * 1985-01-07 1987-02-20 Adir Nouveaux derives peptidiques a structure polycyclique azotee, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US4693993A (en) * 1985-06-13 1987-09-15 Stewart John M Bradykinin antagonist peptides

Also Published As

Publication number Publication date
ATE107318T1 (de) 1994-07-15
NO177597C (no) 1995-10-18
PT91692B (pt) 1995-05-31
FI893738A (fi) 1990-05-25
DE122008000066I1 (de) 2009-05-20
IL91298A (en) 1994-05-30
EP0370453B1 (de) 1994-06-15
SK279315B6 (sk) 1998-09-09
SK490689A3 (en) 1998-09-09
NO893193D0 (no) 1989-08-08
HK1006716A1 (en) 1999-03-12
LU91499I2 (fr) 2009-01-19
LV10720B (en) 1996-02-20
IL91298A0 (en) 1990-03-19
IE892522L (en) 1990-05-24
FI893738A0 (fi) 1989-08-08
HU210712A9 (en) 1995-06-28
DK384089D0 (da) 1989-08-04
AU3943189A (en) 1990-05-31
FI94353C (fi) 1995-08-25
IE63490B1 (en) 1995-05-03
LV10720A (lv) 1995-06-20
JPH07121956B2 (ja) 1995-12-25
CZ490689A3 (en) 1997-03-12
FI94353B (fi) 1995-05-15
EP0370453A2 (de) 1990-05-30
AU612054B2 (en) 1991-06-27
MX9203277A (es) 1992-07-01
CN1042918A (zh) 1990-06-13
DK384089A (da) 1990-05-25
CN1035006C (zh) 1997-05-28
CA1340667C (en) 1999-07-20
NZ230244A (en) 1992-06-25
HU210566B (en) 1995-05-29
DK175344B1 (da) 2004-08-30
NL300359I2 (nl) 2009-02-02
NO2008016I2 (no) 2012-10-01
DE122008000066I2 (de) 2009-11-05
CY2008022I1 (el) 2009-11-04
CY2008022I2 (el) 2009-11-04
HUT52527A (en) 1990-07-28
NL300359I1 (nl) 2008-11-03
KR0139632B1 (ko) 1998-07-01
KR900007870A (ko) 1990-06-02
PT91692A (pt) 1990-03-30
CY2028A (en) 1998-02-20
NO893193L (no) 1990-05-25
DE58907889D1 (de) 1994-07-21
EP0370453A3 (de) 1991-12-04
CZ282384B6 (cs) 1997-07-16
DE3938751A1 (de) 1990-05-31
JPH02184697A (ja) 1990-07-19
PH31009A (en) 1997-12-23
NO177597B (no) 1995-07-10
NO2008016I1 (no) 2008-11-17

Similar Documents

Publication Publication Date Title
ES2057071T3 (es) Peptidos con efecto antagonista de bradiquinina.
DK0788509T3 (da) Terapeutiske peptidderivater
CY1105616T1 (el) ΠΕΠΤΙΔΙΑ ΑΝΑΣΤΟΛΕΙΣ ΤΟΥ TGFβ1
PA8561901A1 (es) Cis-imidazolinas
CO4790174A1 (es) Analogos del peptido lh-rh, sus usos y composiciones farmaceuticas que los contienen
TR200002542T2 (tr) Meta-azasiklik amino benzoik asit bileşikleri ve bunların integrin antagonistleri olan türevleri
CO4230037A1 (es) Composicion para aplicacion topica a la piel y/o cabello a base de tensioactivo de fosfato y co-tensioactivo
ES2170956T3 (es) Derivados 2-alquenilicos de acido ciclopentan(en)oico como agentes terapeuticos en el tratamiento de hipertension ocular.
ES2058873T3 (es) Antagonistas peptidicos sinteticos de neuroquinina a, sus sales y procedimientos de preparacion respectivos.
ATE149520T1 (de) Lhrh-antagonisten
ATE90359T1 (de) Peptide.
DK0579785T3 (da) Substituerede benzhydrylaminer som tlslutningsmolekyler til fastfasepeptidsyntese
ATE276272T1 (de) Entzündungshemmende peptide
CY1113476T1 (el) ΠΕΠΤΙΔΙΑ ΚΑΙ ΠΕΠΤΙΔΟΜΙΜΗΤΙΚΑ ΧΡΗΣΙΜΑ ΓΙΑ ΑΝΑΣΤΟΛΗ ΤΗΣ ΔΡΑΣΤΙΚΟΤΗΤΑΣ ΥΠΟΔΟΧΕΑ ΠΡΟΣΤΑΓΛΑΝΔΙΝΗΣ F2a
CO5300520A1 (es) Nuevos compuestos de sulfonamida y usos de los mismos
ES2064229B1 (es) Nuevas 1,2-dihidro-2-oxopiridinas de formula i.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 370453

Country of ref document: ES